エピソード

  • Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies

    Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
    2025/05/20

    Dr Jennifer Crombie from the Dana-Farber Cancer Institute in Boston, Massachusetts, reviews available and investigational CD20 x CD3 targeted bispecific antibodies for the treatment of follicular and diffuse large B-cell lymphomas.

    CME information and select publications here.

    続きを読む 一部表示
    50 分
  • 5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

    5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
    2025/05/19

    Dr Rinath M Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.

    CME information and select publications here.

    続きを読む 一部表示
    18 分
  • Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit

    Immunotherapy and Nontargeted Approaches for NSCLC — Fourth Annual National General Medical Oncology Summit
    2025/05/18

    Clinical investigators discuss available data guiding the management of non-small cell lung cancer with immunotherapy and other nontargeted approaches. 

    CME information and select publications here.
    続きを読む 一部表示
    50 分
  • Colorectal Cancer — Fourth Annual National General Medical Oncology Summit

    Colorectal Cancer — Fourth Annual National General Medical Oncology Summit
    2025/05/17

    Clinical investigators discuss available data guiding the management of colorectal cancer. 

    CME information and select publications here.
    続きを読む 一部表示
    50 分
  • Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy

    Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy
    2025/05/16

    Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma.

    CME information and select publications here.

    続きを読む 一部表示
    37 分
  • Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances

    Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
    2025/05/14

    Dr Emmanuel S Antonarakis from the University of Minnesota in Minneapolis and Professor Karim Fizazi from the Institut Gustave Roussy in Villejuif, France, provide their perspectives on relevant new clinical data in prostate cancer and discuss their application to the care of patients.

    CME information and select publications here.

    続きを読む 一部表示
    1 時間
  • Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit

    Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit
    2025/05/12

    Clinical investigators discuss available data guiding the management of non-Hodgkin lymphoma. 

    CME information and select publications here.
    続きを読む 一部表示
    50 分
  • Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit

    Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit
    2025/05/11

    Clinical investigators discuss available data guiding the management of gynecologic cancers. 

    CME information and select publications here.
    続きを読む 一部表示
    49 分